The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low dose rate brachytherapy vs standard external beam radiotherapy vs stereotactic body radiotherapy for low risk prostate cancer: A cost-utility analysis.
 
Joelle Antoine Helou
No Relationships to Disclose
 
Sofia Torres
No Relationships to Disclose
 
Hima Bindu Musunuru
No Relationships to Disclose
 
Patrick Cheung
No Relationships to Disclose
 
Danny Vesprini
No Relationships to Disclose
 
Hans T. Chung
Honoraria - Sanofi
 
Laura D'Alimonte
No Relationships to Disclose
 
Ananth Ravi
No Relationships to Disclose
 
Murray Krahn
No Relationships to Disclose
 
Gerard Morton
Honoraria - Abbvie; AstraZeneca; Bayer Schering Pharma; Elekta
 
Andrew Loblaw
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb (I); Elekta; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Paladin; Roche (I); Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Atlas Global Healthcare; Bristol-Myers Squibb (I); GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I); Sanofi
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen Oncology